Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

529711.pdf (693.21 KB)

Document type

Article

Version

Published version

Publication date

1991-12-01

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/177302

Bone marrox regeneration afrer hormonal therapy in patients with bone metastases from prostate carcinoma

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

Abstract

Two patients with prostate carcinoma and bone metastases were treated with hormonal therapy. Radioimmune imaging of bone marrow performed with 99mTc-labeled antigranulocyte antibody BW 250/183 before treatment demonstrated absence of granulopoietic bone marrow in extensive regions of the central and proximal peripheral skeleton, indicating diffuse bone marrow invasion. Bone marrow scans performed after treatment demonstrated presence of granulopoietic bone marrow in these regions, indicating bone marrow regeneration. This finding was consistent with favorable response to treatment.

Subject

Anticossos monoclonals, Medul·la òssia, Càncer d'ossos, Càncer de pròstata

Subject (English)

Monoclonal antibodies, Bone marrow, Bones cancer, Prostate cancer

Citation

Collections

Articles publicats en revistes (Ciències Clíniques)

Citation

BERNÁ, Lluis, et al. Bone marrox regeneration afrer hormonal therapy in patients with bone metastases from prostate carcinoma. Journal of Nuclear Medicine. 1991. Vol. 32, num. 12, pags. 2295-2298. ISSN 0161-5505. [consulted: 9 of August of 2026]. Available at: https://hdl.handle.net/2445/177302

Export metadata

JSON - METS

Share record